Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study

European Journal of Preventive Cardiology
Oyuntugs ByambasukhEva Corpeleijn

Abstract

To investigate prospectively the association of body fat percentage (BF%) estimates using various equations from bioelectrical impedance analysis (BIA) with cardiovascular events, compared with body mass index (BMI) and waist circumference. We used data of 34 BIA-BF%-equations that were used for estimation of BF% in 6486 (men = 3194, women = 3294) subjects. During a median follow-up of 8.3 years, 510 (7.9%) cardiovascular events (363 in men; 147 in women) occurred. In men, the crude hazard ratio (95% confidence interval) for BF% from the best predicting BIA-BF%-equation was 3.97 (3.30-4.78) against 2.13 (1.85-2.45) for BF% from the BIA device's BIA-BF%-equation, 1.34 (1.20-1.49) for BMI and 1.49 (1.40-1.73) for waist circumference per log-1-SD increase of all. In women, the hazard ratios for best predicting BIA-BF%-equation, BIA device estimation, BMI and waist circumference were 3.80 (2.85-4.99), 1.89 (1.57-2.28), 1.35 (1.21-1.51) and 1.52 (1.31-1.75), respectively. After adjustments for age, Framingham cardiovascular disease risk score and creatinine excretion - a marker of muscle mass - BF%s and BMI remained independently associated with cardiovascular events in both men and women, while waist circumference was independently...Continue Reading

References

Sep 1, 1996·The American Journal of Clinical Nutrition·L B HoutkooperW H Howell
Feb 13, 2001·Nutrition·D C FrankenfieldD Becker
Jan 24, 2003·The American Journal of Clinical Nutrition·Jack WangRichard N Pierson
Sep 24, 2004·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Ursula G KyleUNKNOWN Composition of the ESPEN Working Group
Mar 21, 2007·Obesity·Andy MenkeJiang He
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Feb 3, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·P Marques-VidalP Vollenweider
May 7, 2009·JAMA : the Journal of the American Medical Association·Bakhtawar K MahmoodiUNKNOWN Prevention of Renal and Vascular End-stage Disease (PREVEND) Study Group
Jan 18, 2013·European Journal of Clinical Nutrition·A Böhm, B L Heitmann
Jun 17, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·I FlorathH Brenner
Mar 8, 2016·The American Journal of Cardiology·Preethi SrikanthanChi Hong Tseng
Apr 16, 2016·Circulation Research·Mariana GarciaJoAnn E Manson
Jan 11, 2018·European Journal of Preventive Cardiology·Gherardo FinocchiaroMary N Sheppard
Apr 26, 2018·European Journal of Preventive Cardiology·Guy G De Backer
Oct 24, 2018·European Journal of Preventive Cardiology·Yvo Smulders

❮ Previous
Next ❯

Citations

Nov 18, 2020·European Journal of Preventive Cardiology·Geza Halasz, Massimo F Piepoli
Feb 19, 2021·European Journal of Preventive Cardiology·Adela BrahimajMaryam Kavousi
Jun 12, 2021·Frontiers in Medicine·Luis D'MarcoJosé Luis Gorriz
Aug 27, 2021·Journal of Cardiovascular Development and Disease·A-Ra ChoYu-Jin Kwon
Jan 19, 2022·European Journal of Clinical Investigation·Mehmet KanbayKathherine R Tuttle

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
urine collections
urine collection
coronary artery bypass

Software Mentioned

CsChange
survIDINRI
R
PRISMANT
SPSS

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.